Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy

被引：0
|
作者：
D. Francisci
F. Falcinelli
E. Schiaroli
M. Capponi
B. Belfiori
L. Flenghi
F. Baldelli
机构：
[1] University of Perugia,Division of Infectious Diseases, Dept. of Experimental Medicine andBiochemical Science
[2] Ospedale “Santa Maria dellaMisericordia”,Section of Hematology and Clinical Immunology
[3] Dept. of Clinical andExperimental Medicine,undefined
[4] University of Perugia,undefined
来源：
Infection | 2010年 / 38卷
关键词：
Lamivudine; Adefovir; Entecavir; Telbivudine; Logical Malignancy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：58 / 61
页数：3
相关论文
共 50 条
  • [21] Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies
    Idilman, R
    Arat, M
    Soydan, E
    Törüner, M
    Soykan, I
    Akbulut, H
    Arslan, Ö
    Özcan, M
    Türkyilmaz, AR
    Bozdayi, M
    Karayalçin, S
    Van Thiel, DH
    Özden, A
    Beksaç, M
    Akan, H
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (02) : 141 - 147
  • [22] Screening and Prophylaxis to Prevent Hepatitis B Reactivation Patients with Hematological and Solid Tumor Malignancies
    Sasadeusz, Joe
    Grigg, Andrew
    Hughes, Peter D.
    Lim, Seng Lee
    Lucas, Michaela
    McColl, Geoff
    McLachlan, Sue Anne
    Peters, Marion G.
    Shackel, Nicholas
    Slavin, Monica
    Sundararajan, Vijaya
    Thompson, Alexander
    Doyle, Joseph
    Rickard, James
    De Cruz, Peter
    Gish, Robert G.
    Visvanathan, Kumar
    CLINICS IN LIVER DISEASE, 2019, 23 (03) : 511 - +
  • [23] HEPATITIS B VIRUS REACTIVATION IN PATIENTS UNDERGOING CHEMOIMMUNOTHERAPY FOR HAEMATOLOGICAL MALIGNANCIES
    Molagic, Violeta
    Tiliscan, Catalin
    Popescu, Cristina
    Arama, Victoria
    Radulescu, Mihaela
    Vladareanu, Ana Maria
    Arama, Stefan Sorin
    FARMACIA, 2020, 68 (02) : 256 - 260
  • [24] HEPATITIS B VIRUS (HBV) REACTIVATION IN ANTI-HBCAG POSITIVE PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: A PROSPECTIVE MULTICENTER STUDY
    Basso, Maria
    Bosco, Giulia
    Hohaus, Stefan
    Grieco, Antonio
    Laurenti, Luca
    Mansueto, Giovanna
    Pagano, Livio
    Rapaccini, Gian Ludovico
    Sica, Simona
    Farina, Giuliano
    Storti, Sergio
    Valentini, Caterina Giovanna
    D'Andrea, Mariella
    Morrone, Aldo
    Nosotti, Lorenzo
    Petti, Maria Concetta
    Annino, Luciana
    Cortese, Stefania
    Fenu, Susanna
    Pompili, Maurizio
    HEPATOLOGY, 2010, 52 (04) : 678A - 678A
  • [25] Management of hepatitis B virus reactivation during chemotherapy or immunosuppressive therapy
    Amouri, Ali
    Chtourou, Lassaad
    Mnif, Leila
    Tahri, Nabi
    PRESSE MEDICALE, 2008, 37 (11): : 1591 - 1598
  • [26] Hepatitis B virus management to prevent reactivation after chemotherapy: a review
    Hwang, Jessica P.
    Vierling, John M.
    Zelenetz, Andrew D.
    Lackey, Susan C.
    Loomba, Rohit
    SUPPORTIVE CARE IN CANCER, 2012, 20 (11) : 2999 - 3008
  • [27] Risk of hepatitis B virus reactivation in patients treated with ibrutinib
    Hammond, Sarah P.
    Chen, Kaiwen
    Pandit, Alisha
    Davids, Matthew S.
    Issa, Nicolas C.
    Marty, Francisco M.
    BLOOD, 2018, 131 (17) : 1987 - 1989
  • [28] Hepatitis B virus management to prevent reactivation after chemotherapy: a review
    Jessica P. Hwang
    John M. Vierling
    Andrew D. Zelenetz
    Susan C. Lackey
    Rohit Loomba
    Supportive Care in Cancer, 2012, 20 : 2999 - 3008
  • [29] Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy
    Yang, Yu
    Du, Yang
    Luo, Wu-Xia
    Li, Cong
    Chen, Ye
    Cheng, Ke
    Ding, Jing
    Zhou, Yi
    Ge, Jun
    Yang, Xian
    Liu, Ji-Yan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 783 - 790
  • [30] Management of hepatitis B reactivation in patients receiving cancer chemotherapy
    Huang, Yi-Wen
    Chung, Raymond T.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (05) : 359 - 370
12345